Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
76
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Effects of insulin analogs and glucagon-like peptide-1 receptor agonists on proliferation and cellular energy metabolism in papillary thyroid cancer

Liang He1 Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, Liaoning
,
Siliang Zhang2 Department of Endocrinology and Metabolism, The Endocrine Institute and The Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Hospital of China Medical University, Shenyang, Liaoning
,
Xiaowen Zhang3 Department of Endocrinology and Metabolism, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, People’s Republic of China
,
Rui Liu2 Department of Endocrinology and Metabolism, The Endocrine Institute and The Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Hospital of China Medical University, Shenyang, Liaoning
,
Haixia Guan2 Department of Endocrinology and Metabolism, The Endocrine Institute and The Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Hospital of China Medical University, Shenyang, LiaoningCorrespondence[email protected]
&
Hao Zhang1 Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, LiaoningCorrespondence[email protected]
Pages 5621-5631 | Published online: 24 Nov 2017

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Sam Pearson, Noppadol Kietsiriroje & Ramzi A Ajjan. (2019) Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date. Diabetes, Metabolic Syndrome and Obesity 12, pages 2515-2529.
Read now
Na Liu, Hua Yang & Hong Wang. (2018) miR-598 acts as a tumor suppressor in human gastric cancer by targeting IGF-1R. OncoTargets and Therapy 11, pages 2911-2923.
Read now

Articles from other publishers (4)

Zheng Yang, Yuhuan Lv, Meng Yu, Mei Mei, Linyu Xiang, Subei Zhao & Rong Li. (2022) GLP-1 receptor agonist-associated tumor adverse events: A real-world study from 2004 to 2021 based on FAERS. Frontiers in Pharmacology 13.
Crossref
Weiting Hu, Rui Song, Rui Cheng, Caihong Liu, Rui Guo, Wei Tang, Jie Zhang, Qian Zhao, Xing Li & Jing Liu. (2022) Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials. Frontiers in Endocrinology 13.
Crossref
Shabnam Radbakhsh, Stephen L. Atkin, Luis E. Simental-Mendia & Amirhossein Sahebkar. (2021) The role of incretins and incretin-based drugs in autoimmune diseases. International Immunopharmacology 98, pages 107845.
Crossref
Sanjay Kalra, Sameer Aggarwal & Deepak Khandelwal. (2019) Thyroid Dysfunction and Type 2 Diabetes Mellitus: Screening Strategies and Implications for Management. Diabetes Therapy 10:6, pages 2035-2044.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.